Cargando…
A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen
NY-ESO-1 has been a major target of many immunotherapy trials because it is expressed by various cancers and is highly immunogenic. In this study, we have identified a novel HLA-B*1801-restricted CD8(+) T cell epitope, NY-ESO-1(88–96) (LEFYLAMPF) and compared its direct- and cross-presentation to th...
Autores principales: | Zhao, Rona Y., Mifsud, Nicole A., Xiao, Kun, Chan, Kok-Fei, Oveissi, Sara, Jackson, Heather M., Dimopoulos, Nektaria, Guillaume, Philippe, Knights, Ashley J., Lowen, Tamara, Robson, Neil C., Russell, Sarah E., Scotet, Emmanuel, Davis, Ian D., Maraskovsky, Eugene, Cebon, Jonathan, Luescher, Immanuel F., Chen, Weisan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435279/ https://www.ncbi.nlm.nih.gov/pubmed/22970293 http://dx.doi.org/10.1371/journal.pone.0044707 |
Ejemplares similares
-
MEK inhibition, alone or in combination with BRAF inhibition, impairs multiple functions of isolated normal human lymphocytes and dendritic cells
por: Vella, Laura J, et al.
Publicado: (2013) -
Targeting Dendritic Cells in vivo for Cancer Therapy
por: Caminschi, Irina, et al.
Publicado: (2012) -
Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide
por: Chan, Kok Fei, et al.
Publicado: (2018) -
Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes
por: Schmidt, Julien, et al.
Publicado: (2013) -
Resident CD8(+) and Migratory CD103(+) Dendritic Cells Control CD8 T Cell Immunity during Acute Influenza Infection
por: Waithman, Jason, et al.
Publicado: (2013)